ADMA
Adma Biologics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$15.15
+0.16 ▲ +1.07%
🌙 3월 13일 7:40 PM ET (한국 3/14 08:40)
$15.11
-0.04 ▼ -0.29%
| Index | RUT | P/E | 25.29 | EPS (ttm) | 0.6 | Insider Own | 3.59% | Shs Outstand | 0.24B | Perf Week | -1.56% |
| Market Cap | 3.61B | Forward P/E | 11.88 | EPS next Y | 33.51% | Insider Trans | -1.17% | Shs Float | 0.23B | Perf Month | -6.94% |
| Enterprise Value | 3.60B | PEG | 0.34 | EPS next Q | 0.2 | Inst Own | 92.9% | Short Float | 8.33% | Perf Quarter | -24.17% |
| Income | 0.15B | P/S | 7.07 | EPS this Y | 45.41% | Inst Trans | 0.34% | Short Ratio | 7.31 | Perf Half Y | -5.96% |
| Sales | 0.51B | P/B | 7.55 | EPS next 5Y | 34.98% | ROA | 25.97% | Short Interest | 19.14M | Perf YTD | -16.94% |
| Book/sh | 2.01 | P/C | 41.17 | EPS past 3/5Y | - | ROE | 35.56% | 52W High | -40.98% ($25.67) | Perf Year | -15.41% |
| Cash/sh | 0.37 | P/FCF | 129.69 | Sales past 3/5Y | 49.05% 64.6% | ROIC | 26.56% | 52W Low | 10.1% ($13.76) | Perf 3Y | 376.42% |
| Dividend Est. | - | EV/EBITDA | 18.04 | EPS Y/Y TTM | -26.97% | Gross Margin | 57.36% | Volatility(W/M) | 3.82% 5.04% | Perf 5Y | 614.62% |
| Dividend TTM | - | EV/Sales | 7.06 | Sales Y/Y TTM | 19.63% | Oper. Margin | 37.52% | ATR (14) | 0.76 | Perf 10Y | 206.68% |
| Dividend Ex-Date | - | Quick Ratio | 3.74 | EPS Q/Q | -55.49% | Profit Margin | 28.8% | RSI (14) | 40.48 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.71 | Sales Q/Q | 18.39% | SMA20 | -4.33% ($15.84) | Beta | 0.61 | Target Price | $30 |
| Payout | - | Debt/Eq | 0.17 | Earnings | 2000000 | SMA50 | -9.22% ($16.69) | Rel Volume | 1.1 | Prev Close | $14.99 |
| Employees | 647 | LT Debt/Eq | 0.16 | EPS/Sales Surpr. | 15.24% -0.31% | SMA200 | -11.97% ($17.21) | Avg Volume(3M) | 2.62M | Price | $15.15 |
| IPO | 2013/10/17 | Option/Short | Yes/Yes | Trades | 23973 | Volume | 2,875,846 | Change | 1.07% |
뉴스 로딩 중...